Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2

Background: COVID-19 is an infectious disease declared as a global pandemic caused by SARS-CoV-2 virus. Genomic changes in the receptor binding domain (RBD) region of SARS‐CoV‐2 led to an increased, infectivity in humans through interaction with the angiotensin-converting enzyme2 (ACE2) receptor. Si...

Full description

Bibliographic Details
Main Authors: Shankargouda Patil, Khalid J. Alzahrani, Hamsa Jameel Banjer, Ibrahim Faisal Halawani, Hosam Alzahrani, Malik A. Altayar, Sarah Albogami, Robert Fua Angeles, Ali Abdel-Halim Abdel-Azim Hassan, Shilpa Bhandi, A. Thirumal Raj
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034122001502
_version_ 1811238379338072064
author Shankargouda Patil
Khalid J. Alzahrani
Hamsa Jameel Banjer
Ibrahim Faisal Halawani
Hosam Alzahrani
Malik A. Altayar
Sarah Albogami
Robert Fua Angeles
Ali Abdel-Halim Abdel-Azim Hassan
Shilpa Bhandi
A. Thirumal Raj
author_facet Shankargouda Patil
Khalid J. Alzahrani
Hamsa Jameel Banjer
Ibrahim Faisal Halawani
Hosam Alzahrani
Malik A. Altayar
Sarah Albogami
Robert Fua Angeles
Ali Abdel-Halim Abdel-Azim Hassan
Shilpa Bhandi
A. Thirumal Raj
author_sort Shankargouda Patil
collection DOAJ
description Background: COVID-19 is an infectious disease declared as a global pandemic caused by SARS-CoV-2 virus. Genomic changes in the receptor binding domain (RBD) region of SARS‐CoV‐2 led to an increased, infectivity in humans through interaction with the angiotensin-converting enzyme2 (ACE2) receptor. Simultaneously, the genetic variants in ACE2 provide an opportunity for SARS‐CoV‐2 infection and severity. We demonstrate the binding efficiencies of RBDs of SARS‐CoV‐2 strain with ACE2 variants of the human host. Methodology: A Total of 615 SARS‐CoV‐2 genomes were retrieved from repository. Eighteen variations were identified contributing to structural changes in RBD that are distributed in 615 isolates. An analyses of 285 single nucleotide variances at the coding region of the ACE2 receptor showed 34 to be pathogenic. Homology models of 34 ACE2 and 18 RBD structures were constructed with 34 and 18 structural variants, respectively. Protein docking of 612 (34 *18) ACE2-RBD complexes showed variable affinities compared to wildtype Wuhan's and other SARS‐CoV‐2 RBDs, including Omicron B.1.1.529. Finally, molecular dynamic simulation was performed to determine the stability of the complexes. Results: Among 612, the top 3 complexes showing least binding energy were selected. The ACE2 with rs961360700 variant showed the least binding energy (−895.2 Kcal/mol) on binding with the RBD of Phe160Ser variant compared to Wuhan's RBD complex. Interestingly, the binding energy of RBD of Omicron B.1.1.529 with ACE2 (rs961360700) structure showed least binding energy of −1010 Kcal/mol. Additionally, molecular dynamics showed structure stability for all the analysed complexes with the RMSD (0.22–0.26 nm), RMSF (0.11–0.13 nm), and Rg (2.53–2.56 nm). Conclusion: In conclusion, our investigation highlights the clinical variants contributing to structural variants in ACE2 receptors that lead to efficient binding of SARS‐CoV‐2. Therefore, screening of these ACE2 polymorphisms will help detect COVID‐19 risk population so as to provide additional care and for safe management.
first_indexed 2024-04-12T12:41:49Z
format Article
id doaj.art-996af4e1643f45ff8dd38f26f4c9fbd1
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-04-12T12:41:49Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-996af4e1643f45ff8dd38f26f4c9fbd12022-12-22T03:32:46ZengElsevierJournal of Infection and Public Health1876-03412022-07-01157781787Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2Shankargouda Patil0Khalid J. Alzahrani1Hamsa Jameel Banjer2Ibrahim Faisal Halawani3Hosam Alzahrani4Malik A. Altayar5Sarah Albogami6Robert Fua Angeles7Ali Abdel-Halim Abdel-Azim Hassan8Shilpa Bhandi9A. Thirumal Raj10Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan 45412, Saudi Arabia; Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 600077, India; Corresponding author.Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi ArabiaDepartment of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi ArabiaDepartment of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi ArabiaDepartment of Physical Therapy, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi ArabiaDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences,University of Tabuk, Tabuk 71491, Saudi ArabiaDepartment of Biotechnology, College of Science, Taif University, Taif 21944, Saudi ArabiaCollege of Nursing, Jazan University, Jazan 45412, Saudi ArabiaDepartment of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan 45412, Saudi ArabiaDepartment of Restorative Dental Sciences, Division of Operative Dentistry, College of dentistry, Jazan University, Jazan 45412, Saudi Arabia; Department of Cariology. Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 600077, IndiaDepartment of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai 600130, IndiaBackground: COVID-19 is an infectious disease declared as a global pandemic caused by SARS-CoV-2 virus. Genomic changes in the receptor binding domain (RBD) region of SARS‐CoV‐2 led to an increased, infectivity in humans through interaction with the angiotensin-converting enzyme2 (ACE2) receptor. Simultaneously, the genetic variants in ACE2 provide an opportunity for SARS‐CoV‐2 infection and severity. We demonstrate the binding efficiencies of RBDs of SARS‐CoV‐2 strain with ACE2 variants of the human host. Methodology: A Total of 615 SARS‐CoV‐2 genomes were retrieved from repository. Eighteen variations were identified contributing to structural changes in RBD that are distributed in 615 isolates. An analyses of 285 single nucleotide variances at the coding region of the ACE2 receptor showed 34 to be pathogenic. Homology models of 34 ACE2 and 18 RBD structures were constructed with 34 and 18 structural variants, respectively. Protein docking of 612 (34 *18) ACE2-RBD complexes showed variable affinities compared to wildtype Wuhan's and other SARS‐CoV‐2 RBDs, including Omicron B.1.1.529. Finally, molecular dynamic simulation was performed to determine the stability of the complexes. Results: Among 612, the top 3 complexes showing least binding energy were selected. The ACE2 with rs961360700 variant showed the least binding energy (−895.2 Kcal/mol) on binding with the RBD of Phe160Ser variant compared to Wuhan's RBD complex. Interestingly, the binding energy of RBD of Omicron B.1.1.529 with ACE2 (rs961360700) structure showed least binding energy of −1010 Kcal/mol. Additionally, molecular dynamics showed structure stability for all the analysed complexes with the RMSD (0.22–0.26 nm), RMSF (0.11–0.13 nm), and Rg (2.53–2.56 nm). Conclusion: In conclusion, our investigation highlights the clinical variants contributing to structural variants in ACE2 receptors that lead to efficient binding of SARS‐CoV‐2. Therefore, screening of these ACE2 polymorphisms will help detect COVID‐19 risk population so as to provide additional care and for safe management.http://www.sciencedirect.com/science/article/pii/S1876034122001502SARS‐CoV‐2Receptor binding domainAngiotensin-converting enzymeOmicronProtein dockingDynamic simulation
spellingShingle Shankargouda Patil
Khalid J. Alzahrani
Hamsa Jameel Banjer
Ibrahim Faisal Halawani
Hosam Alzahrani
Malik A. Altayar
Sarah Albogami
Robert Fua Angeles
Ali Abdel-Halim Abdel-Azim Hassan
Shilpa Bhandi
A. Thirumal Raj
Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
Journal of Infection and Public Health
SARS‐CoV‐2
Receptor binding domain
Angiotensin-converting enzyme
Omicron
Protein docking
Dynamic simulation
title Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
title_full Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
title_fullStr Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
title_full_unstemmed Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
title_short Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
title_sort receptor binding domain of sars cov 2 from wuhan strain to omicron b 1 1 529 attributes increased affinity to variable structures of human ace2
topic SARS‐CoV‐2
Receptor binding domain
Angiotensin-converting enzyme
Omicron
Protein docking
Dynamic simulation
url http://www.sciencedirect.com/science/article/pii/S1876034122001502
work_keys_str_mv AT shankargoudapatil receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT khalidjalzahrani receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT hamsajameelbanjer receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT ibrahimfaisalhalawani receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT hosamalzahrani receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT malikaaltayar receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT sarahalbogami receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT robertfuaangeles receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT aliabdelhalimabdelazimhassan receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT shilpabhandi receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2
AT athirumalraj receptorbindingdomainofsarscov2fromwuhanstraintoomicronb11529attributesincreasedaffinitytovariablestructuresofhumanace2